oncgnostics

As a biotechnology company, oncgnostics GmbH has been researching cancer diagnostics based on molecular biology since 2012. The company's cancer tests can be used for early cancer detection and diagnosis. Its first product, GynTect®, which originated from the goal of improving the early detection of cervical cancer, is now on the market.